MENU
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lexeo Therapeutics (LXEO) Earnings Date & Reports

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more

A.I. Advisor
published Earnings

LXEO is expected to report earnings to rise 40.00% to -83 cents per share on December 15

Lexeo Therapeutics LXEO Stock Earnings Reports
Q3'25
Est.
$-0.84
Q2'25
Beat
by $0.31
Q1'25
Missed
by $0.10
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.17
The last earnings report on August 14 showed earnings per share of -60 cents, beating the estimate of -91 cents. With 411.46K shares outstanding, the current market capitalization sits at 281.35M.
View a ticker or compare two or three
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LXEO showed earnings on August 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com